ARQT Competitors & Alternatives
Compare Arcutis Biotherapeutics Inc with similar stocks in the same industry
Biotechnology
ARQT
Main Stock$21.01
Tradestie Score
57
Market Cap
$2.37B
Revenue Growth
0.6%
Analyst Upside
+64.8%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.28
|
$2.56B | 18.1 | 51 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 57 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$27.67
|
$2.44B | - | 51 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$63.48
|
$2.42B | - | 58 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$144.25
|
$2.41B | - | 53 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$29.54
|
$2.40B | - | 57 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$82.43
|
$2.35B | - | 50 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$7.74
|
$2.34B | - | 53 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$67.13
|
$2.33B | - | 54 | Compare |
More ARQT Analysis
Data updated: May 21, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry